XERS

Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company leveraging its formulation science expertise to develop and commercialize ready-to-use injectable and infusible drug formulations. The company's marketed products include Gvoke (glucagon injection) for severe hypoglycemia, Keveyis for primary periodic paralysis, and Recorlev for Cushing's syndrome. Xeris focuses on improving patient outcomes through innovative drug delivery solutions.